Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03172754
Title Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

renal cell carcinoma

Therapies

Axitinib + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins Recruiting Baltimore Maryland 21231 United States Details
US Oncology and Hematology Recruiting Albany New York 12206 United States Details
Cornell Recruiting New York New York 10021 United States Details
Fox Chase Cancer Center Recruiting Philadelphia Pennsylvania 19111 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field